EU drugs regulator starts real-time review of CureVac's COVID-19 vaccine

Europe's drugs regulator said on Friday it had started a real-time review of the COVID-19 vaccine developed by German biopharmaceutical firm CureVac.

The European Medicines Agency said the decision by its human medicines committee to start the "rolling review" was based on the vaccine's preliminary results from laboratory studies and early clinical studies in adults. (https://bit.ly/3ddSKh4)